Obesity and Cancer
By K. Wolin, K. Carson, Graham A Colditz. The Oncologist, 2010
1,709 citations recorded by the source corpus.
The article examines the importance of managing weight to reduce risk for developing cancer and for survival among cancer patients and presents a set of strategies that can be useful to guide clinical advice to patients for whom weight control is an important adjunct to risk management or to improve quality of life and disease-free survival after diagnosis.
Subfields: Molecular Biology, Oncology, Physiology
View Paper: https://www.semanticscholar.org/paper/b27026dc78912758434b57f30a5658d6d5df8b89
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
In Physiology
Citations in the corpus
- Shared Risk Factors in Cardiovascular Disease and Cancer (2016, background): “of malignancies could be related to weight, weight gain, and obesity.(25) Based on numerous studies and meta-analyzed data (Figure),(26,27) the American Institute for Cancer Research”
- The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. (2014, methodology): “Among them, 1-5 belong to procedure 1, GB; 6-7 are procedure 2, AGB; 8 and 9 belong to procedure 3, VBG; 10 is procedure 4, SG; and 11 belongs to procedure 5, control.)”
- Immunity, Inflammation, and Cancer (2010, neutral): “Even obesity, which increases cancer risk by 1.6-fold (Calle, 2007), can lead to chronic inflammation (Tuncman et al., 2006) that promotes development of hepatocellular carcinoma (Park et al., 2010).”
- Obesity as a Major Risk Factor for Cancer (2013, background): “There are many prospective epidemiological studies which have demonstrated a direct association between overweight and cancer, even though obesity alone does not apparently heighten cancer risk in all tissues by the same amount [1–7].”
- Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. (2009, background): “Recent epidemiological studies have demonstrated that both T2DM and obesity are associated with an increased risk for many forms of cancer, including cancer of the breast, colon, liver, pancreas, kidney, and others (250, 251).”
- Pathophysiology of human visceral obesity: an update. (2013, background): “Reviews of available epidemiological data reiterated the existence of a significant association between obesity (BMI) and increased risk for several cancers (28, 436).”
- Gallbladder cancer: epidemiology and outcome (2014, neutral): “09 for men.(42,43) Further studies confirm this heightened risk in females (relative risk [RR] =1.”